EJS ACT-PD, the world’s largest clinical trial for Parkinson’s, is now recruiting
Cure Parkinson’s is excited to announce that the first multi-arm multi-stage clinical trial platform for Parkinson’s in the UK – EJS ACT-PD – is underway, with recruitment now open to people with Parkinson’s. The Edmond J. Safra Accelerating Clinical Trials for Parkinson’s Disease (EJS ACT-PD)...
Learn more
An update to our research strategy
Every few years, we set out to review and refresh our research strategy. This document underpins everything we do at Cure Parkinson’s and provides the roadmap for how we plan to move closer to our goal: to identify curative treatments for Parkinson’s, with urgency. As…
How a new study on Parkinson’s in the UK gives insights for research
Parkinson’s UK have recently published the results of their nationwide study, which looked at the prevalence of Parkinson’s in the UK. Information from studies like this help us identify gaps in Parkinson’s research and care. We use these insights to help demonstrate the urgent need…
New funding opportunity: Combination therapies for Parkinson’s
Cure Parkinson’s is excited to announce that we are now accepting expressions of interest for our new combination therapy funding call. In August, Cure Parkinson’s announced we would be opening a £2 million funding call later this year to encourage the testing of combination therapies…
Dr Matthew Farrer wins 2025 Tom Isaacs Award
Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce Dr Matthew Farrer as the winner of the 2025 Tom Isaacs Award, which honours researchers who closely collaborate with the Parkinson’s community. The two organisations were delighted to announce Dr Matthew Farrer as winner…
Combination therapies: a change in approach for Parkinson’s research
As part of our research strategy, Cure Parkinson’s is seeking to progress research involving combination therapies as a potential method for targeting Parkinson’s progression. Currently, clinical trials of potentially disease-modifying therapies for Parkinson’s are largely focussed on testing single drugs, or monotherapies. These drugs often…